{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:43:48Z","timestamp":1790711028640,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07703-3","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T09:34:20Z","timestamp":1768383260000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The NLRP3 inflammasome as a key pathway in the affective and chronic fatigue symptoms of Long COVID"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1208-6070","authenticated-orcid":false,"given":"Yingqian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein Kadhem","family":"Al-Hakeim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hawraa Kadhem","family":"Al-Jassas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2012-871X","authenticated-orcid":false,"given":"Michael","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"7703_CR1","volume-title":"Guideline: managing the long-term effects of COVID-19","author":"COVID-19 rapid","year":"2024","unstructured":"COVID-19 rapid. Guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence (NICE); 2024."},{"key":"7703_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S2213-2600(21)00031-X","volume":"9","author":"P Venkatesan","year":"2021","unstructured":"Venkatesan P. NICE guideline on Long COVID. Lancet Respiratory Med. 2021;9:129.","journal-title":"Lancet Respiratory Med"},{"key":"7703_CR3","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S0140-6736(24)01136-X","volume":"404","author":"T Greenhalgh","year":"2024","unstructured":"Greenhalgh T, Sivan M, Perlowski A, Nikolich J\u017d. Long COVID: a clinical update. Lancet. 2024;404:707\u201324.","journal-title":"Lancet"},{"key":"7703_CR4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/pcn.13508","volume":"77","author":"T Kubota","year":"2023","unstructured":"Kubota T, Kuroda N, Sone D. Neuropsychiatric aspects of Long COVID: A comprehensive review. Psychiatry Clin Neurosci. 2023;77:84\u201393.","journal-title":"Psychiatry Clin Neurosci"},{"key":"7703_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jad.2021.10.039","volume":"297","author":"HK Al-Jassas","year":"2022","unstructured":"Al-Jassas HK, Al-Hakeim HK, Maes M. Intersections between pneumonia, Lowered oxygen saturation percentage and immune activation mediate depression, anxiety, and chronic fatigue syndrome-like symptoms due to COVID-19: A nomothetic network approach. J Affect Disord. 2022;297:233\u201345.","journal-title":"J Affect Disord"},{"key":"7703_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1017\/neu.2022.21","volume":"35","author":"DS Al-Hadrawi","year":"2023","unstructured":"Al-Hadrawi DS, Al-Rubaye HT, Almulla AF, Al-Hakeim HK, Maes M. Lowered oxygen saturation and increased body temperature in acute COVID-19 largely predict chronic fatigue syndrome and affective symptoms due to Long COVID: A precision nomothetic approach. Acta Neuropsychiatrica. 2023;35:76\u201387.","journal-title":"Acta Neuropsychiatrica"},{"key":"7703_CR7","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/s41380-022-01836-9","volume":"28","author":"HK Al-Hakeim","year":"2022","unstructured":"Al-Hakeim HK, Al-Rubaye HT, Al-Hadrawi DS, Almulla AF, Maes M. Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, Lowered antioxidant defenses and inflammation: a proof of concept and mechanism study. Mol Psychiatry. 2022;28:564\u201378.","journal-title":"Mol Psychiatry"},{"key":"7703_CR8","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3390\/jcm12020511","volume":"12","author":"HK Al-Hakeim","year":"2023","unstructured":"Al-Hakeim HK, Al-Rubaye HT, Almulla AF, Al-Hadrawi DS, Maes M. Chronic Fatigue, depression and anxiety symptoms in Long COVID are strongly predicted by neuroimmune and Neuro-Oxidative pathways which are caused by the inflammation during acute infection. J Clin Med. 2023;12:511.","journal-title":"J Clin Med"},{"key":"7703_CR9","doi-asserted-by":"publisher","first-page":"e0316373","DOI":"10.1371\/journal.pone.0316373","volume":"20","author":"WTM Al Masoodi","year":"2025","unstructured":"Al Masoodi WTM, Radhi SW, Abdalsada HK, Niu M, Al-Hakeim HK, Maes M. Increased galanin-galanin receptor 1 signaling, inflammation, and insulin resistance are associated with affective symptoms and chronic fatigue syndrome due to Long COVID. PLoS ONE. 2025;20:e0316373.","journal-title":"PLoS ONE"},{"key":"7703_CR10","first-page":"125","volume":"77","author":"AF Almulla","year":"2022","unstructured":"Almulla AF, Al-Hakeim HK, Maes M. Chronic fatigue and affective symptoms in acute and Long COVID are attributable to immune\u2010inflammatory pathways. J Neuropsychiatry Clin Neurosci. 2022;77:125\u20136.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"7703_CR11","doi-asserted-by":"publisher","first-page":"e20201707","DOI":"10.1084\/jem.20201707","volume":"218","author":"TS Rodrigues","year":"2021","unstructured":"Rodrigues TS, de S\u00e1 KSG, Ishimoto AY, Becerra A, Oliveira S, Almeida L, et al. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J Exp Med. 2021;218:e20201707.","journal-title":"J Exp Med"},{"key":"7703_CR12","doi-asserted-by":"publisher","first-page":"e20202413","DOI":"10.1084\/jem.20202413","volume":"218","author":"C Bryant","year":"2021","unstructured":"Bryant C. COVID-19 Stokes inflammasomes. J Exp Med. 2021;218:e20202413.","journal-title":"J Exp Med"},{"key":"7703_CR13","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/s41380-021-01431-4","volume":"27","author":"M Maes","year":"2022","unstructured":"Maes M, Tedesco Junior WLD, Lozovoy MAB, Mori MTE, Danelli T, Almeida ERDd, et al. In COVID-19, NLRP3 inflammasome genetic variants are associated with critical disease and these effects are partly mediated by the sickness symptom complex: a nomothetic network approach. Mol Psychiatry. 2022;27:1945\u201355.","journal-title":"Mol Psychiatry"},{"key":"7703_CR14","doi-asserted-by":"publisher","first-page":"111337","DOI":"10.1016\/j.humimm.2025.111337","volume":"86","author":"WLDT J\u00fanior","year":"2025","unstructured":"J\u00fanior WLDT, Danelli T, Tano ZN, Cassela PLCS, Trigo GL, Cardoso KdM, et al. Precision medicine and machine learning to predict critical disease and death due to coronavirus disease 2019 (COVID-19). Hum Immunol. 2025;86:111337.","journal-title":"Hum Immunol"},{"key":"7703_CR15","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"V Karen","year":"2019","unstructured":"Karen V, Swason M, Deng, Ting JP-Y. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19:477\u201389.","journal-title":"Nat Rev Immunol"},{"key":"7703_CR16","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41586-019-1295-z","volume":"570","author":"H Sharif","year":"2019","unstructured":"Sharif H, Wang L, Wang WL, Magupalli VG, Andreeva L, Qiao Q, et al. Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome. Nature. 2019;570:338\u201343.","journal-title":"Nature"},{"key":"7703_CR17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3390\/v16020213","volume":"16","author":"Q He","year":"2024","unstructured":"He Q, Hu D, Zheng F, Chen W, Hu K, Liu J, et al. Investigating the nexus of NLRP3 inflammasomes and COVID-19 pathogenesis: unraveling molecular triggers and therapeutic strategies. Viruses. 2024;16:213.","journal-title":"Viruses"},{"key":"7703_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.cytogfr.2021.06.002","volume":"61","author":"N Zhao","year":"2021","unstructured":"Zhao N, Di B, Xu L-l. The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies. Cytokine Growth Factor Rev. 2021;61:2\u201315.","journal-title":"Cytokine Growth Factor Rev"},{"key":"7703_CR19","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","volume":"41","author":"Y He","year":"2016","unstructured":"He Y, Hara H, N\u00fa\u00f1ez G. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci. 2016;41:1012\u201321.","journal-title":"Trends Biochem Sci"},{"key":"7703_CR20","doi-asserted-by":"publisher","first-page":"102387","DOI":"10.1016\/j.coi.2023.102387","volume":"84","author":"TS Rodrigues","year":"2023","unstructured":"Rodrigues TS, Zamboni DS. Inflammasome activation by SARS-CoV-2 and its participation in COVID-19 exacerbation. Curr Opin Immunol. 2023;84:102387.","journal-title":"Curr Opin Immunol"},{"key":"7703_CR21","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41590-021-01104-y","volume":"23","author":"S Mehandru","year":"2022","unstructured":"Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022;23:194\u2013202.","journal-title":"Nat Immunol"},{"key":"7703_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bbi.2024.07.036","volume":"122","author":"AF Almulla","year":"2024","unstructured":"Almulla AF, Thipakorn Y, Zhou B, Vojdani A, Maes M. Immune activation and immune-associated neurotoxicity in Long-COVID: A systematic review and meta-analysis of 103 studies comprising 58 cytokines\/chemokines\/growth factors. Brain Behav Immun. 2024;122:75\u201394.","journal-title":"Brain Behav Immun"},{"key":"7703_CR23","doi-asserted-by":"crossref","unstructured":"van den Berg DF, te, Velde AA. Severe COVID-19: NLRP3 inflammasome dysregulated. Front Immunol. 2020;11:1580.","DOI":"10.3389\/fimmu.2020.01580"},{"key":"7703_CR24","doi-asserted-by":"crossref","unstructured":"Maes M, Almulla AF, You Z, Zhang Y. Neuroimmune, metabolic and oxidative stress pathways in major depressive disorder. Nat Reviews Neurol. 2025.","DOI":"10.1038\/s41582-025-01116-4"},{"key":"7703_CR25","doi-asserted-by":"publisher","first-page":"e1007795","DOI":"10.1371\/journal.ppat.1007795","volume":"15","author":"L Lin","year":"2019","unstructured":"Lin L, Xu L, Lv W, Han L, Xiang Y, Fu L, et al. An NLRP3 inflammasome-triggered cytokine storm contributes to streptococcal toxic shock-like syndrome (STSLS). PloS Pathog. 2019;15:e1007795.","journal-title":"PloS Pathog"},{"key":"7703_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1128\/MMBR.05015-11","volume":"76","author":"JR Tisoncik","year":"2012","unstructured":"Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the eye of the cytokine storm. Microbiol Mol Biology Reviews: MMBR. 2012;76:16\u201332.","journal-title":"Microbiol Mol Biology Reviews: MMBR"},{"key":"7703_CR27","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/s41380-020-00965-3","volume":"26","author":"DE Ribeiro","year":"2021","unstructured":"Ribeiro DE, Oliveira-Giacomelli \u00c1, Glaser T, Arnaud-Sampaio VF, Andrejew R, Dieckmann L, et al. Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology. Mol Psychiatry. 2021;26:1044\u201359.","journal-title":"Mol Psychiatry"},{"key":"7703_CR28","doi-asserted-by":"crossref","unstructured":"Maes M, Almulla AF, You Z, Zhang Y. Neuroimmune, metabolic and oxidative stress pathways in major depressive disorder. Nat Rev Neurol. 2025.","DOI":"10.1038\/s41582-025-01116-4"},{"key":"7703_CR29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12931-020-01445-6","volume":"21","author":"J Xu","year":"2020","unstructured":"Xu J, Xu X, Jiang L, Dua K, Hansbro PM, Liu G. SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis. Respir Res. 2020;21:182.","journal-title":"Respir Res"},{"key":"7703_CR30","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1538-7836.2011.04209.x","volume":"9","author":"A Enzerink","year":"2011","unstructured":"Enzerink A, Vaheri A. Fibroblast activation in vascular inflammation. J Thromb Haemostasis: JTH. 2011;9:619\u201326.","journal-title":"J Thromb Haemostasis: JTH"},{"key":"7703_CR31","doi-asserted-by":"crossref","unstructured":"Ito JT, Louren\u00e7o JD, Righetti RF, Tib\u00e9rio IFLC, Prado CM, Lopes FDTQS. Extracellular matrix component remodeling in respiratory diseases: what has been found in clinical and experimental studies? Cells. 2019;8.","DOI":"10.3390\/cells8040342"},{"key":"7703_CR32","doi-asserted-by":"crossref","unstructured":"Lema\u0144ska-Perek A, Krzy\u017canowska-Go\u0142\u0105b D, Dragan B, Tyszko M, Adamik B. Fibronectin as a marker of disease severity in critically ill COVID-19 patients. Cells. 2022;11.","DOI":"10.3390\/cells11091566"},{"key":"7703_CR33","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41586-022-04702-4","volume":"606","author":"C Junqueira","year":"2022","unstructured":"Junqueira C, Crespo \u00c2, Ranjbar S, de Lacerda LB, Lewandrowski M, Ingber J, et al. Fc\u03b3R-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature. 2022;606:576\u201384.","journal-title":"Nature"},{"key":"7703_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.it.2020.10.012","volume":"42","author":"L Lu","year":"2021","unstructured":"Lu L, Zhang H, Dauphars DJ, He Y-W. A potential role of Interleukin 10 in COVID-19 pathogenesis. Trends Immunol. 2021;42:3\u20135.","journal-title":"Trends Immunol"},{"key":"7703_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/1741-7015-11-205","volume":"11","author":"G Morris","year":"2013","unstructured":"Morris G, Maes M. Myalgic encephalomyelitis\/chronic fatigue syndrome and encephalomyelitis disseminata\/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics. BMC Med. 2013;11:205.","journal-title":"BMC Med"},{"key":"7703_CR36","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41531-017-0032-2","volume":"3","author":"S Sarkar","year":"2017","unstructured":"Sarkar S, Malovic E, Harishchandra DS, Ghaisas S, Panicker N, Charli A, et al. Mitochondrial impairment in microglia amplifies NLRP3 inflammasome Proinflammatory signaling in cell culture and animal models of parkinson\u2019s disease. NPJ Parkinson\u2019s Disease. 2017;3:30.","journal-title":"NPJ Parkinson\u2019s Disease"},{"key":"7703_CR37","doi-asserted-by":"crossref","unstructured":"Kurien BT, Ice JA, Wood RA, Pharaoh G, Cavett J, Lewis V, et al. Mitochondrial dysfunction and fatigue in Sj\u00f6gren\u2019s disease. RMD Open. 2025;11.","DOI":"10.1136\/rmdopen-2024-005046"},{"key":"7703_CR38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12974-016-0539-1","volume":"13","author":"Z-T Zhang","year":"2016","unstructured":"Zhang Z-T, Du X-M, Ma X-J, Zong Y, Chen J-K, Yu C-L, et al. Activation of the NLRP3 inflammasome in lipopolysaccharide-induced mouse fatigue and its relevance to chronic fatigue syndrome. J Neuroinflamm. 2016;13:71.","journal-title":"J Neuroinflamm"},{"key":"7703_CR39","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s44324-025-00079-w","volume":"3","author":"X Che","year":"2025","unstructured":"Che X, Ranjan A, Guo C, Zhang K, Goldsmith R, Levine S, et al. Heightened innate immunity May trigger chronic inflammation, fatigue and post-exertional malaise in ME\/CFS. Npj Metabolic Health Disease. 2025;3:34.","journal-title":"Npj Metabolic Health Disease"},{"key":"7703_CR40","doi-asserted-by":"crossref","unstructured":"Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun. 2022;101.","DOI":"10.1016\/j.bbi.2021.12.020"},{"key":"7703_CR41","doi-asserted-by":"publisher","first-page":"ofab156","DOI":"10.1093\/ofid\/ofab156","volume":"8","author":"SWX Ong","year":"2021","unstructured":"Ong SWX, Fong S-W, Young BE, Chan Y-H, Lee B, Amrun SN, et al. Persistent symptoms and association with inflammatory cytokine signatures in recovered coronavirus disease 2019 patients. Open Forum Infect Dis. 2021;8:ofab156.","journal-title":"Open Forum Infect Dis"},{"key":"7703_CR42","doi-asserted-by":"crossref","unstructured":"Sonnweber T, Sahanic S, Pizzini A, Luger A, Schwabl C, Sonnweber B, et al. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J. 2021;57.","DOI":"10.1183\/13993003.03481-2020"},{"key":"7703_CR43","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1093\/cvr\/cvad084","volume":"119","author":"N Potere","year":"2023","unstructured":"Potere N, Garrad E, Kanthi Y, Di Nisio M, Kaplanski G, Bonaventura A, et al. NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis. Cardiovascular Res. 2023;119:2046\u201360.","journal-title":"Cardiovascular Res"},{"key":"7703_CR44","unstructured":"Rodrigues TS, de S\u00e1 KSG, Ishimoto AY, Becerra A, Oliveira S, Almeida L, et al. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J Exp Med. 2021;218."},{"key":"7703_CR45","first-page":"40","volume":"22","author":"Z Babazadeh","year":"2023","unstructured":"Babazadeh Z. Involvement of NLRP3 inflammasome in SARS-Cov-2-Induced multiorgan dysfunction in patients with COVID-19: A review of molecular mechanisms. Tanaffos. 2023;22:40\u201352.","journal-title":"Tanaffos"},{"key":"7703_CR46","doi-asserted-by":"crossref","unstructured":"Debnath M, Berk M, Maes M. Changing dynamics of psychoneuroimmunology during the COVID-19 pandemic. Brain Behav Immun Health. 2020;5.","DOI":"10.1016\/j.bbih.2020.100096"},{"key":"7703_CR47","doi-asserted-by":"publisher","first-page":"108595","DOI":"10.1016\/j.intimp.2022.108595","volume":"106","author":"S Bakhshi","year":"2022","unstructured":"Bakhshi S, Shamsi S. MCC950 in the treatment of NLRP3-mediated inflammatory diseases: latest evidence and therapeutic outcomes. Int Immunopharmacol. 2022;106:108595.","journal-title":"Int Immunopharmacol"},{"key":"7703_CR48","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1021\/acschembio.1c00218","volume":"16","author":"CR Kennedy","year":"2021","unstructured":"Kennedy CR, Goya Grocin A, Kova\u010di\u010d T, Singh R, Ward JA, Shenoy AR, et al. A probe for NLRP3 inflammasome inhibitor MCC950 identifies carbonic anhydrase 2 as a novel target. ACS Chem Biol. 2021;16:982\u201390.","journal-title":"ACS Chem Biol"},{"key":"7703_CR49","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/S2665-9913(20)30065-5","volume":"2","author":"V Kl\u00fcck","year":"2020","unstructured":"Kl\u00fcck V, Jansen TLTA, Janssen M, Comarniceanu A, Efd\u00e9 M, Tengesdal IW, et al. Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial. Lancet Rheumatol. 2020;2:e270\u201380.","journal-title":"Lancet Rheumatol"},{"key":"7703_CR50","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1089\/neu.2019.6538","volume":"37","author":"HM Eisenberg","year":"2019","unstructured":"Eisenberg HM, Shenton ME, Pasternak O, Simard JM, Okonkwo DO, Aldrich C, et al. Magnetic resonance imaging pilot study of intravenous glyburide in traumatic brain injury. J Neurotrauma. 2019;37:185\u201393.","journal-title":"J Neurotrauma"},{"issue":"Pt 2","key":"7703_CR51","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1469-7793.1997.333bh.x","volume":"503","author":"DN Sheppard","year":"1997","unstructured":"Sheppard DN, Robinson KA. Mechanism of Glibenclamide Inhibition of cystic fibrosis transmembrane conductance regulator Cl- channels expressed in a murine cell line. J Physiol. 1997;503(Pt 2):333\u201346.","journal-title":"J Physiol"},{"key":"7703_CR52","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.7150\/jca.75622","volume":"13","author":"B Oronsky","year":"2022","unstructured":"Oronsky B, Abrouk N, Caroen S, Lybeck M, Guo X, Wang X, et al. A 2022 update on extensive stage Small-Cell lung cancer (SCLC). J Cancer. 2022;13:2945\u201353.","journal-title":"J Cancer"},{"key":"7703_CR53","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.tips.2025.04.007","volume":"46","author":"JE Cabral","year":"2025","unstructured":"Cabral JE, Wu A, Zhou H, Pham MA, Lin S, McNulty R. Targeting the NLRP3 inflammasome for inflammatory disease therapy. Trends Pharmacol Sci. 2025;46:503\u201319.","journal-title":"Trends Pharmacol Sci"},{"key":"7703_CR54","doi-asserted-by":"publisher","first-page":"e2455430","DOI":"10.1001\/jamanetworkopen.2024.55430","volume":"8","author":"DP Shah","year":"2025","unstructured":"Shah DP, Thaweethai T, Karlson EW, Bonilla H, Horne BD, Mullington JM, et al. Sex differences in Long COVID. JAMA Netw Open. 2025;8:e2455430.","journal-title":"JAMA Netw Open"},{"key":"7703_CR55","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3892\/etm.2022.11290","volume":"23","author":"V Efstathiou","year":"2022","unstructured":"Efstathiou V, Stefanou M-I, Demetriou M, Siafakas N, Makris M, Tsivgoulis G, et al. Long COVID and neuropsychiatric manifestations (Review). Experimental Therapeutic Med. 2022;23:363.","journal-title":"Experimental Therapeutic Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07703-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07703-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07703-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T16:03:04Z","timestamp":1770652984000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07703-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7703"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07703-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Every participant signed a written informed consent form. The research obtained authorization from the Najaf Health Directorate Training and Human Development Center and the institutional ethics board of the University of Kufa, as documented with the numbers 4316\u2009\u2212\u20092024\/1\/29. The research complied with Iraqi and international ethical and privacy regulations, including the International Conference on Harmonization of Good Practice, the Belmont Report, the CIOMS Guidelines, and the Declaration of Helsinki by the World Medical Association. Furthermore, our institutional review board adheres to the International Guidelines for Human Research Safety (ICH-GCP).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors state that they have no financial conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"166"}}